GARP
iShares MSCI USA Quality GARP ETF
GARP tracks an index composed of U.S. large- and mid-capitalization growth stocks exhibiting favorable value and quality characteristics.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 1.6 B
ASSETS UNDER MGMT
15 bp
EXPENSES
Fund Basics
| Inception date | Jan 14, 2020 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | Yes |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| LAM RESEARCH CORP | 5.6 % |
| NVIDIA CORP | 5.1 % |
| APPLE INC | 4.9 % |
| META PLATFORMS INC | 4.9 % |
| MICROSOFT CORP | 4.6 % |
| KLA CORPORATION | 3.5 % |
| ALPHABET INC. CLASS A | 3.3 % |
| AMPHENOL CORP-CL A | 3.2 % |
| VISA INC. CLASS A | 3.1 % |
| MICRON TECHNOLOGY INC | 2.9 % |
Constituent Breakdown
| Number of holdings | 147 |
| Herfindahl-Hirschman Index | 247 |
| Wgt avg mkt cap (mns) | $1,095,366 |
| Large cap (>$10bn) | 98.8% |
| Mid cap ($2-10bn) | 0.5% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 98.7% |
| Emerging mkts. | 0.2% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 98.0 % |
 |
IRELAND | 0.6 % |
Historical Performance
Standardized Performance (as of 04/24/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -- | -- | -- | -- | -- | -- | -- | -- |
| Dividend Yield | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Returns | -- | -- | -- | -- | -- | -- | -- | -- | Ann. Volatility | -- | -- | -- | -- | -- | -- | -- | -- |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.00 | 0% |
| MSCI EAFE | 0.00 | 0% |
| MSCI Emg Mkts | 0.00 | 0% |
Liquidity Measures
| Avg. volume (000) | 249 |
| ADV traded (mns) | $18 |
| Turnover | 1.1% |
| Avg. Bid/Ask (% of price) | 0.06% |
Technical Indicators
| 30d moving avg. (EMA) | $67.56 |
| Relative strength (RSI) | 62 |
| MACD/Signal | 1.29/0.42 |
| Bollinger Bands (Upper/Lower) | $72.60/$60.62 |
| Short interest (% of AUM) | 0.6% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. GARP |
Expenses vs. GARP |
ALTAR Score™ vs. GARP |
|---|---|---|---|---|
| QRMI | Global X NASDAQ 100 Risk Managed Income ETF | 44.9% | +45 bp | -0.4% |
| QYLD | Global X NASDAQ 100 Covered Call ETF | 44.9% | +45 bp | -0.6% |
| QYLG | Global X Nasdaq 100 Covered Call & Growth ETF | 44.6% | +45 bp | -0.8% |
| QCLR | Global X NASDAQ 100 Collar 95-110 ETF | 44.3% | +10 bp | -0.2% |
| QTR | Global X NASDAQ 100 Tail Risk ETF | 44.2% | +11 bp | -0.5% |
| MMLG | First Trust Multi-Manager Large Growth ETF | 44.0% | +70 bp | -2.5% |
| XYLD | Global X S&P 500 Covered Call ETF | 43.9% | +45 bp | +0.2% |
| XRMI | Global X S&P 500 Risk Managed Income ETF | 43.8% | +45 bp | +0.3% |
| XYLG | Global X S&P 500 Covered Call & Growth ETF | 43.4% | +45 bp | 0.0% |
| XCLR | Global X S&P 500 Collar 95-110 ETF | 42.9% | +10 bp | +0.4% |
Risk and Returns: GARP vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 4/24/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
4.5%
ALTAR SCORE™
32nd
PERCENTILE
UNDERWEIGHT
ETFRC RATING
There are 1,196 funds in the US Equity category with an average
ALTAR Score™ of 5.5% and a standard deviation
of 2.1%. GARP's ALTAR Score™ is approximately -0.5 standard
deviations above the category average. This places GARP in the 32nd percentile
among funds in the category.
Sell-Side Consensus
$84.56
PRICE TARGET
+17.2%
UPSIDE